|
PLEKHA9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.75709999953256E-07 |
| Normal-vs-Stage2 |
1.776170E-04 |
| Normal-vs-Stage3 |
1.39890321548819E-11 |
| Normal-vs-Stage4 |
1.65401026208656E-12 |
| Stage1-vs-Stage2 |
9.665600E-02 |
| Stage1-vs-Stage3 |
1.567620E-04 |
| Stage1-vs-Stage4 |
9.44580003103823E-09 |
| Stage2-vs-Stage3 |
2.113200E-01 |
| Stage2-vs-Stage4 |
1.296660E-03 |
| Stage3-vs-Stage4 |
9.480500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
8.842200E-04 |
| Normal-vs-Asian |
1.803590E-01 |
| Caucasian-vs-AfricanAmerican |
1.705770E-02 |
| Caucasian-vs-Asian |
4.996200E-01 |
| AfricanAmerican-vs-Asian |
3.386600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62481139653892E-12 |
| Normal-vs-Female |
1.68789981991324E-10 |
| Male-vs-Female |
3.855600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.110200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.55351295663786E-15 |
| Normal-vs-Age(61-80Yrs) |
1.13390408174041E-11 |
| Normal-vs-Age(81-100Yrs) |
4.196200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.981800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.857200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.988800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.801560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.769600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.799600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.859600E-01 |
| Normal-vs-Grade 2 |
1.00279999970532E-07 |
| Normal-vs-Grade 3 |
1.87683202312883E-12 |
| Normal-vs-Grade 4 |
2.40918396343659E-14 |
| Grade 1-vs-Grade 2 |
3.372300E-02 |
| Grade 1-vs-Grade 3 |
6.428500E-04 |
| Grade 1-vs-Grade 4 |
1.05349999834914E-08 |
| Grade 2-vs-Grade 3 |
1.504080E-02 |
| Grade 2-vs-Grade 4 |
4.57719999680251E-08 |
| Grade 3-vs-Grade 4 |
1.72679999999037E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.73420000000913E-05 |
| Normal-vs-ccB subtype |
1.63369318073592E-12 |
| ccA subtype-vs-ccB subtype |
4.86450002501471E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.80375722638837E-12 |
| Normal-vs-N1 |
3.876200E-03 |
| N0-vs-N1 |
5.676200E-02 |
|
|
